1	Upregulation	Upregulation	B-NP	NN	O	8	SUB	17	Upregulation
2	of	of	B-PP	IN	O	1	NMOD	0
3	vascular	vascular	B-NP	JJ	B-protein	7	NMOD	0
4	endothelial	endothelial	I-NP	JJ	I-protein	7	NMOD	0
5	growth	growth	I-NP	NN	I-protein	7	NMOD	0
6	factor	factor	I-NP	NN	I-protein	7	NMOD	0
7	receptors	receptor	I-NP	NNS	I-protein	2	PMOD	0
8	is	be	B-VP	VBZ	O	0	ROOT	0
9	associated	associate	I-VP	VBN	O	8	VC	0
10	with	with	B-PP	IN	O	9	VMOD	0
11	advanced	advance	B-NP	VBN	O	12	NMOD	0
12	neuroblastoma	neuroblastoma	I-NP	NN	B-cell_type	10	PMOD	0
13	.	.	O	.	O	8	P	0

1	BACKGROUND	BACKGROUND	B-NP	NN	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Angiogenesis	Angiogenesis	B-NP	NN	O	4	SUB	3	Angiogenesis
4	is	be	B-VP	VBZ	O	1	NMOD	0
5	essential	essential	B-ADJP	JJ	O	4	PRD	17	essential
6	for	for	B-PP	IN	O	5	AMOD	0
7	tumor	tumor	B-NP	NN	O	8	NMOD	0
8	growth	growth	I-NP	NN	O	6	PMOD	4	growth
9	and	and	O	CC	O	4	VMOD	0
10	relies	rely	B-VP	VBZ	O	4	VMOD	0
11	on	on	B-PP	IN	O	10	VMOD	0
12	the	the	B-NP	DT	O	13	NMOD	0
13	production	production	I-NP	NN	O	11	PMOD	0
14	of	of	B-PP	IN	O	13	NMOD	0
15	angiogenic	angiogenic	B-NP	JJ	B-protein	16	NMOD	3	angiogenic
16	factors	factor	I-NP	NNS	I-protein	14	PMOD	0
17	.	.	O	.	O	4	P	0

1	Vascular	Vascular	B-NP	JJ	B-protein	4	NMOD	0
2	endothelial	endothelial	I-NP	JJ	I-protein	4	NMOD	0
3	growth	growth	I-NP	NN	I-protein	4	NMOD	0
4	factor	factor	I-NP	NN	I-protein	8	SUB	0
5	(	(	O	(	O	7	DEP	0
6	VEGF	VEGF	B-NP	NN	B-protein	7	DEP	0
7	)	)	O	)	O	4	NMOD	0
8	is	be	B-VP	VBZ	O	0	ROOT	0
9	a	a	B-NP	DT	O	11	NMOD	0
10	major	major	I-NP	JJ	O	11	NMOD	0
11	regulator	regulator	I-NP	NN	O	8	PRD	0
12	of	of	B-PP	IN	O	11	NMOD	0
13	angiogenesis	angiogenesis	B-NP	NN	O	12	PMOD	3	angiogenesis
14	that	that	B-NP	WDT	O	13	NMOD	0
15	binds	bind	B-VP	VBZ	O	14	SBAR	15	binds
16	to	to	B-PP	TO	O	15	VMOD	0
17	tyrosine	tyrosine	B-NP	NN	B-protein	19	NMOD	0
18	kinase	kinase	I-NP	NN	I-protein	19	NMOD	0
19	receptors	receptor	I-NP	NNS	I-protein	16	PMOD	0
20	Flt-1	Flt-1	I-NP	NN	B-protein	22	NMOD	0
21	and	and	I-NP	CC	O	22	NMOD	0
22	KDR	KDR	I-NP	NN	B-protein	19	NMOD	0
23	.	.	O	.	O	8	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	interaction	interaction	I-NP	NN	O	7	NMOD	15	interaction
3	of	of	B-PP	IN	O	2	NMOD	0
4	VEGF	VEGF	B-NP	NN	B-protein	3	PMOD	0
5	and	and	O	CC	O	7	NMOD	0
6	its	its	B-NP	PRP$	O	7	NMOD	0
7	receptors	receptor	I-NP	NNS	O	0	ROOT	0
8	at	at	B-PP	IN	O	7	NMOD	0
9	gene	gene	B-NP	NN	O	12	NMOD	0
10	and	and	I-NP	CC	O	12	NMOD	0
11	protein	protein	I-NP	NN	O	12	NMOD	0
12	levels	level	I-NP	NNS	O	8	PMOD	0
13	in	in	B-PP	IN	O	12	NMOD	0
14	neuroblastoma	neuroblastoma	B-NP	NN	B-cell_type	15	SUB	0
15	remains	remain	B-VP	VBZ	O	13	SBAR	0
16	widely	widely	B-ADJP	RB	O	17	AMOD	0
17	unknown	unknown	I-ADJP	JJ	O	15	PRD	0
18	.	.	O	.	O	7	P	0

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	Tumor	Tumor	B-NP	NN	O	5	NMOD	0
4	biopsy	biopsy	I-NP	NN	O	5	NMOD	0
5	specimens	specimen	I-NP	NNS	O	7	NMOD	0
6	and	and	O	CC	O	7	NMOD	0
7	serum	serum	B-NP	NN	O	8	SUB	0
8	were	be	B-VP	VBD	O	24	VMOD	0
9	obtained	obtain	I-VP	VBN	O	8	VC	0
10	from	from	B-PP	IN	O	9	VMOD	0
11	37	37	B-NP	CD	O	13	NMOD	0
12	neuroblastoma	neuroblastoma	I-NP	NN	O	13	NMOD	0
13	patients	patient	I-NP	NNS	O	10	PMOD	0
14	;	;	O	:	O	24	P	0
15	adrenal	adrenal	B-NP	JJ	O	17	NMOD	0
16	biopsy	biopsy	I-NP	NN	O	17	NMOD	0
17	sections	section	I-NP	NNS	O	19	NMOD	0
18	and	and	I-NP	CC	O	19	NMOD	0
19	sera	serum	I-NP	NNS	O	24	SUB	0
20	of	of	B-PP	IN	O	19	NMOD	0
21	7	7	B-NP	CD	O	23	NMOD	0
22	normal	normal	I-NP	JJ	O	23	NMOD	0
23	children	child	I-NP	NNS	O	20	PMOD	0
24	served	serve	B-VP	VBD	O	1	NMOD	0
25	as	as	B-PP	IN	O	24	VMOD	0
26	controls	control	B-NP	NNS	O	25	PMOD	0
27	.	.	O	.	O	1	P	0

1	Biopsy	Biopsy	B-NP	NN	O	2	NMOD	0
2	specimens	specimen	I-NP	NNS	O	3	SUB	0
3	were	be	B-VP	VBD	O	20	VMOD	0
4	examined	examine	I-VP	VBN	O	3	VC	0
5	by	by	B-PP	IN	O	4	VMOD	0
6	real-time	real-time	B-NP	JJ	O	11	NMOD	0
7	reverse	reverse	I-NP	JJ	O	11	NMOD	0
8	transcription	transcription	I-NP	NN	O	11	NMOD	0
9	polymerase	polymerase	I-NP	NN	O	11	NMOD	0
10	chain	chain	I-NP	NN	O	11	NMOD	0
11	reaction	reaction	I-NP	NN	O	17	NMOD	0
12	(	(	O	(	O	14	DEP	0
13	RT-PCR	RT-PCR	B-NP	NN	O	14	DEP	0
14	)	)	O	)	O	11	NMOD	0
15	and	and	O	CC	O	17	NMOD	0
16	Western	Western	B-NP	NN	O	17	NMOD	0
17	blotting	blotting	I-NP	NN	O	5	PMOD	0
18	;	;	O	:	O	20	P	0
19	serum	serum	B-NP	NN	O	20	SUB	0
20	was	be	B-VP	VBD	O	0	ROOT	0
21	analyzed	analyze	I-VP	VBN	O	20	VC	0
22	by	by	B-PP	IN	O	21	VMOD	0
23	enzyme-linked	enzyme-linked	B-NP	JJ	O	25	NMOD	0
24	immunosorbent	immunosorbent	I-NP	JJ	O	25	NMOD	0
25	assay	assay	I-NP	NN	O	22	PMOD	0
26	(	(	O	(	O	28	DEP	0
27	ELISA	ELISA	B-NP	NN	O	28	DEP	0
28	)	)	O	)	O	25	NMOD	0
29	.	.	O	.	O	20	P	0

1	VEGF-A	VEGF-A	B-NP	NN	B-protein	13	NMOD	0
2	(	(	O	(	O	4	DEP	0
3	165	165	B-NP	CD	O	4	DEP	0
4	)	)	O	)	O	1	NMOD	0
5	,	,	O	,	O	13	P	0
6	B	B	B-NP	NN	O	13	NMOD	0
7	,	,	O	,	O	13	P	0
8	C	C	B-NP	NN	B-protein	13	NMOD	0
9	,	,	O	,	O	13	P	0
10	Flt-1	Flt-1	B-NP	NN	B-protein	13	NMOD	0
11	,	,	O	,	O	13	P	0
12	and	and	O	CC	O	13	NMOD	0
13	KDR	KDR	B-NP	NN	B-protein	14	SUB	0
14	were	be	B-VP	VBD	O	0	ROOT	0
15	analyzed	analyze	I-VP	VBN	O	14	VC	0
16	.	.	O	.	O	14	P	0

1	RESULTS	RESULTS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	VEGF	VEGF	B-NP	NN	B-protein	4	NMOD	0
4	isoforms	isoform	I-NP	NNS	I-protein	9	NMOD	0
5	and	and	O	CC	O	9	NMOD	0
6	its	its	B-NP	PRP$	O	9	NMOD	0
7	receptors	receptor	I-NP	NNS	O	8	NMOD	0
8	'	'	B-NP	POS	B-RNA	9	NMOD	0
9	mRNA	mRNA	I-NP	NN	I-RNA	10	SUB	0
10	were	be	B-VP	VBD	O	1	NMOD	0
11	expressed	express	I-VP	VBN	O	10	VC	10	expressed
12	in	in	B-PP	IN	O	11	VMOD	0
13	neuroblastoma	neuroblastoma	B-NP	NN	B-cell_type	16	NMOD	0
14	and	and	I-NP	CC	O	16	NMOD	0
15	control	control	I-NP	NN	O	16	NMOD	0
16	tissues	tissue	I-NP	NNS	O	12	PMOD	0
17	.	.	O	.	O	1	P	0

1	Whereas	Whereas	B-SBAR	IN	O	14	VMOD	0
2	the	the	B-NP	DT	O	3	NMOD	0
3	ligands	ligand	I-NP	NNS	O	4	SUB	0
4	were	be	B-VP	VBD	O	1	SBAR	0
5	increased	increase	I-VP	VBN	O	4	VC	0
6	in	in	B-PP	IN	O	5	VMOD	0
7	stages	stage	B-NP	NNS	O	6	PMOD	0
8	III	III	B-NP	CD	O	10	NMOD	0
9	and	and	I-NP	CC	O	10	NMOD	0
10	IV	IV	I-NP	CD	O	7	NMOD	0
11	,	,	O	,	O	14	P	0
12	the	the	B-NP	DT	O	13	NMOD	0
13	receptors	receptor	I-NP	NNS	O	14	SUB	0
14	were	be	B-VP	VBD	O	0	ROOT	0
15	upregulated	upregulate	I-VP	VBN	O	14	VC	0
16	in	in	B-PP	IN	O	15	VMOD	0
17	stage	stage	B-NP	NN	O	16	PMOD	0
18	III	III	I-NP	CD	O	17	NMOD	0
19	only	only	B-ADVP	RB	O	15	VMOD	0
20	.	.	O	.	O	14	P	0

1	At	At	B-PP	IN	O	13	VMOD	0
2	protein	protein	B-NP	NN	O	3	NMOD	0
3	level	level	I-NP	NN	O	1	PMOD	0
4	,	,	O	,	O	13	P	0
5	VEGF-B	VEGF-B	B-NP	NN	B-protein	12	NMOD	0
6	and	and	I-NP	CC	O	12	NMOD	0
7	C	C	I-NP	NN	O	12	NMOD	0
8	,	,	O	,	O	12	P	0
9	Flt-1	Flt-1	B-NP	NN	B-protein	12	NMOD	0
10	,	,	O	,	O	12	P	0
11	and	and	O	CC	O	12	NMOD	0
12	KDR	KDR	B-NP	NN	B-protein	13	SUB	0
13	were	be	B-VP	VBD	O	0	ROOT	0
14	not	not	B-ADJP	RB	O	13	VMOD	0
15	detectable	detectable	I-ADJP	JJ	O	13	PRD	9	detectable
16	in	in	B-PP	IN	O	13	VMOD	0
17	tissue	tissue	B-NP	NN	O	18	NMOD	0
18	lysates	lysate	I-NP	NNS	O	16	PMOD	0
19	,	,	O	,	O	13	P	0
20	whereas	whereas	O	IN	O	13	VMOD	0
21	VEGF-A	VEGF-A	B-NP	NN	B-protein	22	SUB	0
22	was	be	B-VP	VBD	O	20	SBAR	0
23	increased	increase	I-VP	VBN	O	22	VC	17	increased
24	in	in	B-PP	IN	O	23	VMOD	0
25	stages	stage	B-NP	NNS	O	24	PMOD	0
26	III	III	B-NP	CD	O	28	NMOD	0
27	and	and	I-NP	CC	O	28	NMOD	0
28	IV	IV	I-NP	CD	O	25	NMOD	0
29	.	.	O	.	O	13	P	0

1	Serum	Serum	B-NP	NN	B-protein	4	NMOD	0
2	VEGF	VEGF	I-NP	NN	I-protein	4	NMOD	0
3	protein	protein	I-NP	NN	I-protein	4	NMOD	0
4	levels	level	I-NP	NNS	O	5	SUB	0
5	were	be	B-VP	VBD	O	0	ROOT	0
6	upregulated	upregulate	I-VP	VBN	O	5	VC	17	upregulated
7	in	in	B-PP	IN	O	6	VMOD	0
8	stage	stage	B-NP	NN	O	7	PMOD	0
9	III	III	I-NP	CD	O	8	NMOD	0
10	.	.	O	.	O	5	P	0

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	0	ROOT	0
2	:	:	O	:	O	1	P	0
3	VEGF-A	VEGF-A	B-NP	NN	O	7	SUB	0
4	(	(	O	(	O	6	DEP	0
5	165	165	B-NP	CD	O	6	DEP	0
6	)	)	O	)	O	3	NMOD	0
7	is	be	B-VP	VBZ	O	22	VMOD	0
8	one	one	B-NP	CD	O	7	OBJ	0
9	of	of	B-PP	IN	O	8	NMOD	0
10	the	the	B-NP	DT	O	13	NMOD	0
11	major	major	I-NP	JJ	O	13	NMOD	0
12	angiogenesis	angiogenesis	I-NP	NN	O	13	NMOD	3	angiogenesis
13	regulators	regulator	I-NP	NNS	O	9	PMOD	0
14	among	among	B-PP	IN	O	13	NMOD	0
15	the	the	B-NP	DT	O	17	NMOD	0
16	ligands	ligand	I-NP	NNS	O	17	NMOD	0
17	'	'	B-NP	POS	O	18	NMOD	0
18	family	family	I-NP	NN	O	14	PMOD	0
19	of	of	B-PP	IN	O	18	NMOD	0
20	VEGF	VEGF	B-NP	NN	B-protein	19	PMOD	0
21	,	,	O	,	O	22	P	0
22	whereas	whereas	O	IN	O	1	NMOD	0
23	its	its	B-NP	PRP$	O	24	NMOD	0
24	receptors	receptor	I-NP	NNS	O	32	SUB	0
25	KDR	KDR	I-NP	NN	B-protein	30	NMOD	0
26	,	,	O	,	O	30	P	0
27	and	and	O	CC	O	30	NMOD	0
28	most	most	B-NP	RBS	O	29	AMOD	0
29	probably	probably	I-NP	RB	O	30	NMOD	0
30	Flt-1	Flt-1	I-NP	NN	B-protein	24	NMOD	0
31	,	,	O	,	O	24	P	0
32	may	may	B-VP	MD	O	22	SBAR	0
33	contribute	contribute	I-VP	VB	O	32	VC	0
34	to	to	B-PP	TO	O	33	VMOD	0
35	a	a	B-NP	DT	O	37	NMOD	0
36	poor	poor	I-NP	JJ	O	37	NMOD	0
37	prognosis	prognosis	I-NP	NN	O	41	NMOD	0
38	(	(	O	(	O	40	DEP	0
39	angiogenic	angiogenic	O	JJ	O	40	DEP	3	angiogenic
40	)	)	O	)	O	37	NMOD	0
41	phenotype	phenotype	B-NP	NN	O	34	PMOD	0
42	,	,	O	,	O	33	P	0
43	as	as	B-SBAR	IN	O	33	VMOD	0
44	indicated	indicate	B-VP	VBN	O	43	SBAR	0
45	by	by	B-PP	IN	O	44	VMOD	0
46	their	their	B-NP	PRP$	O	49	NMOD	0
47	upregulated	upregulate	I-NP	VBN	O	49	NMOD	0
48	MRNA	MRNA	I-NP	NN	B-RNA	49	NMOD	0
49	levels	level	I-NP	NNS	O	45	PMOD	0
50	in	in	B-PP	IN	O	49	NMOD	0
51	stage	stage	B-NP	NN	O	53	NMOD	0
52	III	III	I-NP	CD	O	53	NMOD	0
53	neuroblastoma	neuroblastoma	I-NP	NN	B-cell_type	50	PMOD	0
54	.	.	O	.	O	1	P	0

1	VEGF-A	VEGF-A	B-NP	NN	B-protein	6	SUB	0
2	(	(	O	(	O	4	DEP	0
3	165	165	B-NP	CD	O	4	DEP	0
4	)	)	O	)	O	1	NMOD	0
5	mainly	mainly	B-ADVP	RB	O	6	VMOD	0
6	contributes	contribute	B-VP	VBZ	O	0	ROOT	16	contributes
7	to	to	B-PP	TO	O	6	VMOD	0
8	increased	increase	B-NP	VBN	O	11	NMOD	17	increased
9	serum	serum	I-NP	NN	O	11	NMOD	0
10	VEGF	VEGF	I-NP	NN	O	11	NMOD	0
11	levels	level	I-NP	NNS	O	7	PMOD	0
12	and	and	O	CC	O	6	VMOD	0
13	may	may	B-VP	MD	O	6	VMOD	0
14	serve	serve	I-VP	VB	O	13	VC	0
15	as	as	B-PP	IN	O	14	VMOD	0
16	a	a	B-NP	DT	O	18	NMOD	0
17	diagnostic	diagnostic	I-NP	JJ	O	18	NMOD	0
18	tool	tool	I-NP	NN	O	15	PMOD	0
19	in	in	B-PP	IN	O	18	NMOD	0
20	advanced-stage	advanced-stage	B-NP	JJ	B-cell_type	21	NMOD	0
21	neuroblastoma	neuroblastoma	I-NP	NN	I-cell_type	19	PMOD	0
22	.	.	O	.	O	6	P	0

